BioLineRx (NASDAQ:BLRX) Earns “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of BioLineRx (NASDAQ:BLRX – Free Report) in a report released on Wednesday,Benzinga reports. Several other research firms have also recently weighed in on BLRX. Wall Street Zen began coverage on shares of BioLineRx in a research report on Sunday, May 18th. They issued a “sell” rating on […]
HC Wainwright reaffirmed their buy rating on shares of BioLineRx (NASDAQ:BLRX – Free Report) in a report released on Wednesday,Benzinga reports. Several other research firms have also recently weighed in on BLRX. Wall Street Zen began coverage on shares of BioLineRx in a research report on Sunday, May 18th. They issued a “sell” rating on […]
